Cerebral tau pathology in cerebral amyloid angiopathy
Brain Communications · 2024-03-01 · 6 (2)
DOI: 10.1093/braincomms/fcae086 ↗At a glance
Journal article in Brain Communications, published online on 2024-03-12. Written by Hsin-Hsi Tsai and 6 co-authors. Institution: Department of Neurology, National Taiwan University Hospital, Taipei 100225, Taiwan. Cited 17 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: Taiwan National Science and Technology Council, National Taiwan University Hospital.
Abstract (original language)
Tau, a hallmark of Alzheimer’s disease, is poorly characterized in cerebral amyloid angiopathy. We aimed to assess the clinico-radiological correlations between tau positron emission tomography scans and cerebral amyloid angiopathy. We assessed cerebral amyloid and hyperphosphorylated tau in patients with probable cerebral amyloid angiopathy (n = 31) and hypertensive small vessel disease (n = 27) using 11C-Pittsburgh compound B and 18F-T807 positron emission tomography. Multivariable regression models were employed to assess radio-clinical features related to cerebral tau pathology in cerebral amyloid angiopathy. Cerebral amyloid angiopathy exhibited a higher cerebral tau burden in the inferior temporal lobe [1.25 (1.17–1.42) versus 1.08 (1.05–1.22), P < 0.001] and all Braak stage regions of interest (P < 0.05) than hypertensive small vessel disease, although the differences were attenuated after age adjustment. Cerebral tau pathology was significantly associated with cerebral amyloid angiopathy-related vascular markers, including cortical superficial siderosis (β = 0.12, 95% confidence interval 0.04–0.21) and cerebral amyloid angiopathy score (β = 0.12, 95% confidence interval 0.03–0.21) after adjustment for age, ApoE4 status and whole cortex amyloid load. Tau pathology correlated significantly with cognitive score (Spearman’s ρ=−0.56, P = 0.001) and hippocampal volume (−0.49, P = 0.007), even after adjustment. In conclusion, tau pathology is more frequent in sporadic cerebral amyloid angiopathy than in hypertensive small vessel disease. Cerebral amyloid angiopathy-related vascular pathologies, especially cortical superficial siderosis, are potential markers of cerebral tau pathology suggestive of concomitant Alzheimer’s disease.
Subjects
Author keywords
Authors and institutions
- Department of Neurology, National Taiwan University Hospital, Taipei 100225, Taiwan.
- Department of Nuclear Medicine, National Taiwan University Hospital, Taipei 100225, Taiwan.
- Department of Medical Imaging, National Taiwan University Hospital, Taipei 100225, Taiwan.
ORCID profiles: Hsin-Hsi Tsai
Funding
- Taiwan National Science and Technology Council
- National Taiwan University Hospital
Cite
APA
Tsai, H. H., Liu, C. J., Lee, B. C., Chen, Y. F., Yen, R. F., Jeng, J. S., & Tsai, L. K. (2024). Cerebral tau pathology in cerebral amyloid angiopathy. Brain Communications, 6(2). https://doi.org/10.1093/braincomms/fcae086
Vancouver
Tsai HH, Liu CJ, Lee BC, Chen YF, Yen RF, Jeng JS, et al. Cerebral tau pathology in cerebral amyloid angiopathy. Brain Communications. 2024;6(2). doi:10.1093/braincomms/fcae086
BibTeX
@article{Tsai2024,
author = {Tsai, Hsin-Hsi and Liu, Chia-Ju and Lee, Bo-Ching and Chen, Ya-Fang and Yen, Ruoh-Fang and Jeng, Jiann-Shing and Tsai, Li-Kai},
title = {Cerebral tau pathology in cerebral amyloid angiopathy},
journal = {Brain Communications},
year = {2024},
volume = {6},
number = {2},
doi = {10.1093/braincomms/fcae086}
}
EUVIMED